Company intelligence
Candesic
CEO level clarity with R&D level insight
About Candesic
Candesic is a leading specialist healthcare, pharma & life sciences and medtech management consulting firm. Our consulting services include strategy, vendor / commercial due diligence, digital and M&A/growth. We work with global private equity funds and other private investors, as well as their portfolio companies, healthcare corporates and public sector organisations such as the NHS. Since our foundation in 2002, we have completed ca 800 consulting assignments across Europe, the Middle East, the Americas and Australia. Our professional team combines deep strategic, medical and scientific expertise, allowing us to deliver a unique value proposition to our clients: CEO level clarity with R&D level insight.
Verified activity
Signals from Candesic
6 published signals
Presence & Recognition
Candesic has been shortlisted for Commercial Due Diligence Provider of the Year at the Mergermarket European Private Equity Awards 2026.
Reported by Candesic
Strategy & Corporate Development
Candesic supported the commercial due diligence for Spire Healthcare Group plc to recommend a £1bn takeover by an investor consortium owned by Toscafund Asset Management LLP, Three Hills (THCP Advisory), and Ares Management.
Reported by Candesic
People
Candesic provided commercial due diligence for the consortium to Spire Healthcare Group plc through Tulip UK Bidco.
Reported by Candesic
Presence & Recognition
Candesic is hosting an event featuring Rabia T. K. and the Serna Bio team in Abu Dhabi.
Reported by Samin Saeed
People
Candesic welcomed Maria Vara as Senior Analyst and new interns Hugo Baumgartner, Max Carnegie Brown, and Dr. Toby Speirs.
Reported by Candesic
People
Candesic welcomed Amanda Liu, Andre Johannesen, Deeplata Jha, Hersh Punjani, Joe Turner, and Thomas Künow as full-time Analysts.
Reported by Candesic